Brain Single-Cell Transcriptional Responses to Bexarotene-Activated RXR in an Alzheimer’s Disease Model
International Journal of Molecular Sciences · 06.03.2026 · 27 (5) · 2435
DOI: 10.3390/ijms27052435 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.03.2026. Verfasst von Carolina Saibro-Girardi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental and Occupational Health, University of Pittsburgh, Pittsburgh, PA 15261, USA. Hauptthemen laut MEDLINE: Bexarotene, Alzheimer Disease, Retinoid X Receptors, Brain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Health (NIH), National Institutes of Health, USA, Improvement of Higher Education Personnel.
Themen: Demenz
Abstract (Originalsprache)
Pharmacological activation of brain Retinoid X Receptors (RXRs) enhances cognition and facilitates amyloid-beta (Aβ) clearance in Alzheimer’s disease (AD) mouse models, partly by upregulating apolipoprotein E (Apoe), a major AD genetic risk factor. However, the specific cellular contributions to these effects are unclear. Here, we used single-cell transcriptomic profiling to investigate cell subpopulation-specific responses to bexarotene, an RXR agonist, in APP/PS1 mice. Our analysis revealed that bexarotene activated cholesterol biosynthesis and lipid metabolism transcriptional programs in homeostatic astrocytes and oligodendrocytes. Astrocytes also upregulated neurodevelopmental genes, while oligodendrocytes and endothelial cells showed enhanced protein folding and cellular growth pathways. Bexarotene further modulated immune responses, promoting Aβ-responsive signatures in disease-associated microglia and reactive astrocytes while dampening pro-inflammatory responses in homeostatic microglia and endothelial cells. Furthermore, Apoe expression was significantly elevated across multiple cell types, especially in microglia and oligodendrocytes. Cell–cell communication analysis highlighted increased astrocyte-centered signaling, with APOE-driven pathways emerging as a prominent mediator. These findings clarify the molecular complexity of RXR-mediated regulation, revealing the cellular origins of bexarotene’s known effects as well as novel, cell-type-specific responses. This study provides mechanistic insights into RXR-targeted interventions and supports APOE-associated pathways as promising therapeutic targets in AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Environmental and Occupational Health, University of Pittsburgh, Pittsburgh, PA 15261, USA.
- Cell and Molecular Biology Graduate Program, Biotechnology Center, Federal University of Rio Grande do Sul, Porto Alegre 91501-970, RS, Brazil.
ORCID-Profile: Yi Lu, Nicholas F Fitz, Iliya Lefterov, Radosveta Koldamova
Förderung
- National Institute of Health (NIH)
- National Institutes of Health, USA
- Improvement of Higher Education Personnel
- National Council for Scientific and Technological Development (CNPq), Brazil
Zitieren
APA
Saibro-Girardi, C., Lu, Y., Fitz, N. F., Gelain, D. P., Lefterov, I., & Koldamova, R. (2026). Brain Single-Cell Transcriptional Responses to Bexarotene-Activated RXR in an Alzheimer’s Disease Model. International Journal of Molecular Sciences, 27(5), 2435. https://doi.org/10.3390/ijms27052435
Vancouver
Saibro-Girardi C, Lu Y, Fitz NF, Gelain DP, Lefterov I, Koldamova R. Brain Single-Cell Transcriptional Responses to Bexarotene-Activated RXR in an Alzheimer’s Disease Model. International Journal of Molecular Sciences. 2026;27(5):2435. doi:10.3390/ijms27052435
BibTeX
@article{SaibroGirardi2026,
author = {Saibro-Girardi, Carolina and Lu, Yi and Fitz, Nicholas F and Gelain, Daniel P and Lefterov, Iliya and Koldamova, Radosveta},
title = {Brain Single-Cell Transcriptional Responses to Bexarotene-Activated RXR in an Alzheimer’s Disease Model},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {5},
pages = {2435},
doi = {10.3390/ijms27052435}
}
EUVIMED